Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

BMJ 2011; 342 doi: (Published 11 January 2011)
Cite this as: BMJ 2011;342:c7086

Related articles

Research: Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trial

Practice: Non-steroidal anti-inflammatory drugs (NSAIDs)

Research: Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study

Letter: Results can be summarised in a simple figure

Research: All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study

Editorial: Cardiovascular safety of NSAIDs

Fillers: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Education and debate: Simultaneous comparison of multiple treatments: combining direct and indirect evidence

Paper: Bias in meta-analysis detected by a simple, graphical test

Paper: Statistics notes: Absence of evidence is not evidence of absence

See more

Endgames: What is an “n-of-1” trial?

Editorial: Ruling out DVT using the Wells rule and a D-dimer test

Practice: How effective is tranexamic acid for acute gastrointestinal bleeding?

News: NICE keeps paracetamol in UK guidelines on osteoarthritis

This article has been cited by other articles: